Asacol

This page contains recent news articles, when available, and an overview of Asacol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Warner Chilcott: An Undervalued Growth Play  -  ‎Dec 21, 2009‎
The company's diversified portfolio of branded products include popular names like Actonel and Asacol, which generated over $2 billion in sales last year. ... Sumfolio.com

Many Sources of Upside for WCRX  -  ‎Dec 9, 2009‎
Asacol and Actonel would be converted into versions with longer patent lives. Morgan Stanley expects WCRX's SG&A expenses to decline during 2015, ... Benzinga

Cititorii intreaba, medicul raspunde  -  ‎Dec 13, 2009‎
Sunt ingrijorat, insa, deoarece medicul meu mi-a zis ca va trebui sa iau toata viata Asacol. Exista cercetari cu privire la utilizarea pe termen lung a ... Cronica Română

æ—¥ 제약업계 올해ì—?ë?„ M&A 잇따ë?¼  -  ‎Dec 30, 2009‎
...티롯ì?€ ì—¼ì¦?성 장질환 치료제 '아사콜'(Asacol, mesalamine)ì?´ íŒ?매구성비ì?˜ 81%를 차지할 ì •ë?„로 하부소화기분야ì—? 강한 전문제약회사로, 유럽과 중ë?™ 등 세계 50개국 ... 디지틀보사

P&G closes deal to sell drug arm  -  ‎Oct 30, 2009‎
Warner Chilcott acquires P&G's portfolio of brand-name prescription drugs, including Asacol, a treatment for ulcerative colitis; Actonel, an osteoporosis ... Cincinnati.com

Study demonstrates once-daily dose of Asacol(R) (mesalamine) is comparable to ...  -  ‎Oct 28, 2009‎
The study, which met its primary endpoint of non-inferiority, found that 90.5 per cent of patients taking Asacol once-daily remained in remission at six ... CNW Telbec (Communiqué de presse)

Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 ...  -  ‎Oct 26, 2009‎
Pentasa® is a registered trademark of Ferring A/S. Asacol® is a registered trademark of Medeva Pharma Schweiz AG. Dipentum® is a registered trademark of UCB ... Reuters

Warner Chilcott Q3 Profit Soars On Licensing Deal Gains - Update  -  ‎Nov 9, 2009‎
...ulcerative colitis drug Asacol HD, female sexual-dysfunction drug Intrinsa and the co-promotion rights to overactive bladder treatment drug Enablex. ... Trading Markets (press release)

Patients Previously on Steroids Maintain Remission From Ulcerative Colitis ...  -  ‎Oct 27, 2009‎
SAN DIEGO -- October 27, 2009 -- Even among patients who have previously used corticosteroids to control ulcerative colitis, ... DG News

Une étude prouve qu'une dose quotidienne unique d'Asacol(R) (mésalazine ...  -  ‎Oct 28, 2009‎
L'étude, qui prouve la borne de non-infériorité, a déterminé que 90,5 pour cent des patients qui prennent de l'Asacol une fois par jour restaient en ... Canada NewsWire (press release)

æ—¥ '서바릭스' 'ìž?누비아' 등 신약 대거 승ì?¸  -  ‎Oct 20, 2009‎
...제리아신약ì?˜ 궤양성대장염 치료제 '아사콜'(Asacol, mesalamine)ê³¼ 다ì?´ë‹›í?°ìŠ¤ë¯¸í† ëª¨ì œì•½ì?˜ 간세í?¬ì•” 치료제 '미리플ë?¼'(Miripla, miriplatin)ë?„ 승ì?¸ë??다. ... 디지틀보사





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy